Lanean...

Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study

OBJECTIVE: Cognitive measures that are sensitive to biological markers of Alzheimer disease (AD) pathology are needed in order to (a) facilitate preclinical staging, (b) identify individuals who are at the highest risk for developing clinical symptoms and (c) serve as endpoints for evaluating the ef...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Int Neuropsychol Soc
Egile Nagusiak: Aschenbrenner, Andrew J., Balota, David A., Fagan, Anne M., Duchek, Janet M., Benzinger, Tammie L.S., Morris, John C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4610253/
https://ncbi.nlm.nih.gov/pubmed/26416094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1355617715000776
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!